UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.37 -0.11 (-0.14%) GOLD FUTURES
2,322.50 -8.70 (-0.37%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,354.37 -371.16 (-0.73%)
Roche Holding AG (0TDF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 02:43PM BST
| Previous close | 30.16 |
| Open | 30.37 |
| Bid | 28.10 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 30.37 - 30.37 |
| 52-week range | 30.37 - 40.26 |
| Volume | |
| Avg. volume | 352 |
| Market cap | 2.069B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 0.15 |
| EPS (TTM) | 2.07 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.